163 related articles for article (PubMed ID: 34731936)
1. Whole-Exome Sequencing in Papillary Microcarcinoma: Potential Early Biomarkers of Lateral Lymph Node Metastasis.
Kim M; Kwon CH; Jang MH; Kim JM; Kim EH; Jeon YK; Kim SS; Choi KU; Kim IJ; Park M; Kim BH
Endocrinol Metab (Seoul); 2021 Oct; 36(5):1086-1094. PubMed ID: 34731936
[TBL] [Abstract][Full Text] [Related]
2. Extensive lymphatic spread of papillary thyroid microcarcinoma is associated with an increase in expression of genes involved in epithelial-mesenchymal transition and cancer stem cell-like properties.
Lee S; Bae JS; Jung CK; Chung WY
Cancer Med; 2019 Nov; 8(15):6528-6537. PubMed ID: 31498560
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological Features and Molecular Signatures of Lateral Neck Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.
Lim J; Lee HS; Heo JH; Song YS
Endocrinol Metab (Seoul); 2024 Apr; 39(2):324-333. PubMed ID: 38572535
[TBL] [Abstract][Full Text] [Related]
4. Mutational profile of papillary thyroid microcarcinoma with extensive lymph node metastasis.
Jeon MJ; Chun SM; Lee JY; Choi KW; Kim D; Kim TY; Jang SJ; Kim WB; Shong YK; Song DE; Kim WG
Endocrine; 2019 Apr; 64(1):130-138. PubMed ID: 30645724
[TBL] [Abstract][Full Text] [Related]
5. Features of papillary thyroid microcarcinoma associated with lateral cervical lymph node metastasis.
Jeon MJ; Chung MS; Kwon H; Kim M; Park S; Baek JH; Song DE; Sung TY; Hong SJ; Kim TY; Kim WB; Shong YK; Lee JH; Kim WG
Clin Endocrinol (Oxf); 2017 Jun; 86(6):845-851. PubMed ID: 28273370
[TBL] [Abstract][Full Text] [Related]
6. The role of the tumor microenvironment in papillary thyroid microcarcinoma nodal metastasis.
Kim M; Kwon CH; Kim BH
Endocr Relat Cancer; 2024 Aug; 31(8):. PubMed ID: 38768280
[TBL] [Abstract][Full Text] [Related]
7. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
[TBL] [Abstract][Full Text] [Related]
8. Analysis of differential BRAF(V600E) mutational status in high aggressive papillary thyroid microcarcinoma.
Lee X; Gao M; Ji Y; Yu Y; Feng Y; Li Y; Zhang Y; Cheng W; Zhao W
Ann Surg Oncol; 2009 Feb; 16(2):240-5. PubMed ID: 19034577
[TBL] [Abstract][Full Text] [Related]
9. Cell adhesion-related gene somatic mutations are enriched in aggressive papillary thyroid microcarcinomas.
Song J; Wu S; Xia X; Wang Y; Fan Y; Yang Z
J Transl Med; 2018 Oct; 16(1):269. PubMed ID: 30285776
[TBL] [Abstract][Full Text] [Related]
10. Can Cervical Lymph Node Metastasis Increase the Risk of Distant Metastasis in Papillary Thyroid Carcinoma?
Wang W; Ding Y; Jiang W; Li X
Front Endocrinol (Lausanne); 2022; 13():917794. PubMed ID: 35813656
[TBL] [Abstract][Full Text] [Related]
11. Extent of lateral neck dissection for papillary thyroid microcarcinomas.
Lee JH; Chun YS; Chung YS
Head Neck; 2019 May; 41(5):1367-1371. PubMed ID: 30536753
[TBL] [Abstract][Full Text] [Related]
12. Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome.
Sapuppo G; Palermo F; Russo M; Tavarelli M; Masucci R; Squatrito S; Vigneri R; Pellegriti G
J Endocrinol Invest; 2017 Dec; 40(12):1355-1363. PubMed ID: 28646475
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of whole-exome sequencing in fine-needle aspiration specimens of papillary thyroid microcarcinoma for the identification of novel gene mutations.
Ma L; Gao L; Hu Y; Li X; Liu C; Ji J; Shi X; Pan A; An Y; Luo N; Xia Y; Jiang Y
Clin Genet; 2024 May; 105(5):567-572. PubMed ID: 38326996
[TBL] [Abstract][Full Text] [Related]
14. Real-Time PCR Cycle Threshold Values for the BRAFV600E Mutation in Papillary Thyroid Microcarcinoma May Be Associated With Central Lymph Node Metastasis: A Retrospective Study.
Park VY; Kim EK; Lee HS; Moon HJ; Yoon JH; Kwak JY
Medicine (Baltimore); 2015 Jul; 94(28):e1149. PubMed ID: 26181555
[TBL] [Abstract][Full Text] [Related]
15. Clinical predictors of lymph node metastasis and survival rate in papillary thyroid microcarcinoma: analysis of 3607 patients at a single institution.
Xu Y; Xu L; Wang J
J Surg Res; 2018 Jan; 221():128-134. PubMed ID: 29229118
[TBL] [Abstract][Full Text] [Related]
16. Papillary microcarcinoma of the thyroid: clinical characteristics and BRAF(V600E) mutational status of 977 cases.
Zheng X; Wei S; Han Y; Li Y; Yu Y; Yun X; Ren X; Gao M
Ann Surg Oncol; 2013 Jul; 20(7):2266-73. PubMed ID: 23370668
[TBL] [Abstract][Full Text] [Related]
17. Endoplasmic reticulum aminopeptidase 2 is highly expressed in papillary thyroid microcarcinoma with cervical lymph node metastasis.
Kim WY; Lee JB; Kim HY; Woo SU; Son GS; Bae JW
J Cancer Res Ther; 2015; 11(2):443-6. PubMed ID: 26148615
[TBL] [Abstract][Full Text] [Related]
18. Which papillary thyroid microcarcinoma should be treated as "true cancer" and which as "precancer"?
Kaliszewski K; Diakowska D; Wojtczak B; Forkasiewicz Z; Pupka D; Nowak Ł; Rudnicki J
World J Surg Oncol; 2019 May; 17(1):91. PubMed ID: 31146753
[TBL] [Abstract][Full Text] [Related]
19. The optimal extent of lymph node dissection in N1b papillary thyroid microcarcinoma based on clinicopathological factors and preoperative ultrasonography.
Liu XN; Duan YS; Yue K; Wu YS; Zhang WC; Wang XD
Gland Surg; 2022 Jun; 11(6):1047-1056. PubMed ID: 35800750
[TBL] [Abstract][Full Text] [Related]
20. Central lymph node metastasis is an important prognostic factor in patients with papillary thyroid microcarcinoma.
Lee J; Song Y; Soh EY
J Korean Med Sci; 2014 Jan; 29(1):48-52. PubMed ID: 24431905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
